NEW YORK (Reuters Health) – As a treatment strategy for early Parkinson disease, initial therapy with levodopa versus pramipexole appears to make little difference in terms of eventual…
NEW YORK (Reuters Health) – For first-line tocolytic therapy before 32 weeks’ gestation, prostaglandin inhibitors appear to be the most effective and tolerable agents for delaying delivery for…
NEW YORK (Reuters Health) – Reducing blood pressure with the drug combination perindopril-indapamide reduces renal events in patients with type 2 diabetes, even when the initial blood pressure…
NEW YORK (Reuters Health) – After finding that the 5-HT3 receptor in the brain affects susceptibility to opioid dependence, scientists in California have demonstrated the efficacy of ondansetron,…
NEW YORK (Reuters Health) – The results of a small trial suggest that vitamin B12 is a safe, effective, and inexpensive treatment for recurrent aphthous stomatitis (RAS). “The…
NEW YORK (Reuters Health) – The risk of visual field loss with the antiepileptic drug vigabatrin is lower when it is given during infancy rather than later in…
NEW YORK (Reuters Health) – An ultrasensitive assessment of HIV-RNA levels in HAART-treated patients with subclinical viral loads reveals that nevirapine-based regimens are more effective in this setting…
NEW YORK (Reuters Health) – The results of a sham-controlled trial suggest that pneumatic compression devices (PCDs) can produce clinically significant improvements in patients with restless legs syndrome.…
By David Douglas NEW YORK (Reuters Health) – There appears to be a link between genetically controlled serotonergic modulation of amygdala activity and placebo-induced relief of anxiety, Swedish…
Current long-term use of calcium channel blockers was associated with a significantly reduced risk of a Parkinson disease diagnosis, while the risk was not materially altered for users…